<?xml version="1.0" encoding="UTF-8"?>
<ref id="B147">
 <label>147.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Beinborn</surname>
    <given-names>NA</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Du</surname>
    <given-names>J</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Wiederhold</surname>
    <given-names>NP</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Smyth</surname>
    <given-names>HD</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Williams</surname>
    <given-names>RO</given-names>
    <suffix>3rd</suffix>
   </name>
  </person-group>
  <article-title>Dry powder insufflation of crystalline and amorphous voriconazole formulations produced by thin film freezing to mice</article-title>. 
  <source>Eur. J. Pharm. Biopharm.</source>
  <volume>81</volume>(
  <issue>3</issue>), 
  <fpage>600</fpage>â€“
  <lpage>608</lpage> (
  <year>2012</year>).
  <pub-id pub-id-type="pmid">22569473</pub-id>
 </mixed-citation>
</ref>
